Arban Domi

654 total citations
21 papers, 496 citations indexed

About

Arban Domi is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Arban Domi has authored 21 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 10 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Arban Domi's work include Poxvirus research and outbreaks (8 papers), Virus-based gene therapy research (7 papers) and Herpesvirus Infections and Treatments (5 papers). Arban Domi is often cited by papers focused on Poxvirus research and outbreaks (8 papers), Virus-based gene therapy research (7 papers) and Herpesvirus Infections and Treatments (5 papers). Arban Domi collaborates with scholars based in United States, France and Uganda. Arban Domi's co-authors include Bernard Moss, Suany Ojeda, Andrea S. Weisberg, Georges Beaud, Farshad Guirakhoo, Nathanael McCurley, Rahul Basu, Harriet L. Robinson, Liliana Maruri‐Avidal and Nisha K. Duggal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Nature Methods.

In The Last Decade

Arban Domi

20 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arban Domi United States 11 239 233 182 136 122 21 496
François Guiguen France 17 318 1.3× 315 1.4× 142 0.8× 191 1.4× 132 1.1× 42 672
Danilo Bretas de Oliveira Brazil 12 119 0.5× 96 0.4× 105 0.6× 36 0.3× 99 0.8× 32 450
James H. Cox Germany 9 148 0.6× 255 1.1× 142 0.8× 74 0.5× 82 0.7× 16 410
Marcin Smreczak Poland 12 119 0.5× 413 1.8× 221 1.2× 147 1.1× 72 0.6× 45 608
Theresa Sergel United States 11 544 2.3× 133 0.6× 144 0.8× 162 1.2× 79 0.6× 12 596
Christina McCracken United Kingdom 7 192 0.8× 125 0.5× 161 0.9× 90 0.7× 41 0.3× 8 393
Armelle Vigouroux France 4 131 0.5× 59 0.3× 272 1.5× 47 0.3× 106 0.9× 4 473
E. V. Gavrilova Russia 11 367 1.5× 243 1.0× 160 0.9× 51 0.4× 214 1.8× 43 503
A. L. Schmaljohn United States 7 297 1.2× 366 1.6× 345 1.9× 84 0.6× 265 2.2× 8 748
F. Costy Belgium 9 170 0.7× 288 1.2× 117 0.6× 125 0.9× 77 0.6× 13 470

Countries citing papers authored by Arban Domi

Since Specialization
Citations

This map shows the geographic impact of Arban Domi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arban Domi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arban Domi more than expected).

Fields of papers citing papers by Arban Domi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arban Domi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arban Domi. The network helps show where Arban Domi may publish in the future.

Co-authorship network of co-authors of Arban Domi

This figure shows the co-authorship network connecting the top 25 collaborators of Arban Domi. A scholar is included among the top collaborators of Arban Domi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arban Domi. Arban Domi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, Shannon, Arban Domi, Pratima Kumari, et al.. (2025). Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model. Vaccines. 13(4). 411–411. 1 indexed citations
2.
Malherbe, Delphine C., Arban Domi, Caroline Atyeo, et al.. (2022). A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection. npj Vaccines. 7(1). 83–83. 7 indexed citations
3.
Malherbe, Delphine C., Arban Domi, Michelle Meyer, et al.. (2020). Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. npj Vaccines. 5(1). 331–344. 15 indexed citations
4.
Salvato, María S., Arban Domi, Sandra Medina-Moreno, et al.. (2019). A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge. Pathogens. 8(3). 133–133. 25 indexed citations
5.
Domi, Arban, Friederike Feldmann, Rahul Basu, et al.. (2018). A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge. Scientific Reports. 8(1). 864–864. 33 indexed citations
6.
Brault, Aaron C., Arban Domi, Erin McDonald, et al.. (2017). A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model. Scientific Reports. 7(1). 14769–14769. 90 indexed citations
7.
McCurley, Nathanael, Arban Domi, Rahul Basu, et al.. (2017). HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site. PLoS ONE. 12(10). e0177863–e0177863. 9 indexed citations
8.
Guirakhoo, Farshad, Arban Domi, Nathanael McCurley, & Harriet L. Robinson. (2016). Development of a Zika vaccine using a novel MVA-VLP platform. International Journal of Infectious Diseases. 53. 16–17. 2 indexed citations
9.
Zhang, Xinsheng, Arban Domi, Kevin J. Wright, et al.. (2015). Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein. Virology. 482. 218–224. 10 indexed citations
10.
Zhang, Xinsheng, Kevin J. Wright, Martín Bäcker, et al.. (2013). Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector. Virology. 446(1-2). 25–36. 4 indexed citations
11.
Morrow, Gavin, César Boggiano, Maryline Panis, et al.. (2012). Evaluation of a replication-competent VSV-SIV vaccine candidate. Retrovirology. 9(S2). 1 indexed citations
12.
Maruri‐Avidal, Liliana, Arban Domi, Andrea S. Weisberg, & Bernard Moss. (2011). Participation of Vaccinia Virus L2 Protein in the Formation of Crescent Membranes and Immature Virions. Journal of Virology. 85(6). 2504–2511. 36 indexed citations
13.
Domi, Arban, Andrea S. Weisberg, & Bernard Moss. (2008). Vaccinia Virus E2L Null Mutants Exhibit a Major Reduction in Extracellular Virion Formation and Virus Spread. Journal of Virology. 82(9). 4215–4226. 30 indexed citations
14.
Hebben, Matthias, Catherine Birck, Jean‐Pierre Samama, et al.. (2007). High level protein expression in mammalian cells using a safe viral vector: Modified vaccinia virus Ankara. Protein Expression and Purification. 56(2). 269–278. 18 indexed citations
15.
Ojeda, Suany, Arban Domi, & Bernard Moss. (2006). Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion Complex. Journal of Virology. 80(19). 9822–9830. 63 indexed citations
16.
Domi, Arban & Bernard Moss. (2005). Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage λ–based recombination. Nature Methods. 2(2). 95–97. 37 indexed citations
17.
Domi, Arban & Bernard Moss. (2002). Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proceedings of the National Academy of Sciences. 99(19). 12415–12420. 75 indexed citations
18.
Domi, Arban & Georges Beaud. (2000). The punctate sites of accumulation of vaccinia virus early proteins are precursors of sites of viral DNA synthesis. Microbiology. 81(5). 1231–1235. 27 indexed citations
19.
Domi, Arban, Georges Beaud, & A. Favre. (1996). Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs. Biochimie. 78(7). 654–662. 8 indexed citations
20.
Domi, Arban, et al.. (1995). PHOTOINACTIVATION (365 NM) OF VACCINIA AND HERPES SIMPLEX VIRUSES INDUCED BY A NEW BUILT‐IN DNA PHOTOSENSITIZER: 4‐THIOTHYMIDINE. Photochemistry and Photobiology. 61(5). 463–470. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Guiguen Breakdown of academic impact, for papers by Danilo Bretas de Oliveira Breakdown of academic impact, for papers by James H. Cox Breakdown of academic impact, for papers by Marcin Smreczak Breakdown of academic impact, for papers by Theresa Sergel Breakdown of academic impact, for papers by Christina McCracken Breakdown of academic impact, for papers by Armelle Vigouroux Breakdown of academic impact, for papers by E. V. Gavrilova Breakdown of academic impact, for papers by A. L. Schmaljohn Breakdown of academic impact, for papers by F. Costy
Rankless by CCL
2026